Public Lecture: New Approaches to Treatment of Depression and Bipolar Disorder (Part 2 of 4)

Public Lecture: New Approaches to Treatment of Depression and Bipolar Disorder (Part 2 of 4)
This lecture titled “New Approaches to Treatment of Depression and Bipolar Disorder” was presented by Dr. Husseini Manji who is the Global Head of Neuroscien…


 

 

Prospective Grant of Exclusive Patent License: Use of Scopolamine to Treat
Aug 27, 2013 (Menafn – FIND, Inc. via COMTEX) –SUMMARY: This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive … Read more on MENAFN.COM

Recovering from depression with Dr. Corneau
“The FDA in the UK says: 'No anti-depressant is recommended for the initial treatment of mild depression,'” she said. According to Dr. C, Dr. Nedley's program is 90% successful. She said she first heard of his program on the radio. As a counselor, she … Read more on The Wilton Bulletin

Shutting off neurons helps bullied mice overcome symptoms of depression
A new drug target to treat depression and other mood disorders may lie in a group of GABA neurons (gamma-aminobutyric acid –the neurotransmitters which inhibit other cells) shown to contribute to symptoms like social withdrawal and increased anxiety, … Read more on Medical Xpress